Unlocking ROCK2 inhibition in the CNS

Ovid Therapeutics Inc. published this content on May 01, 2023, and is solely responsible for the information contained herein. Distributed via Public Technologies (PUBT), unedited and unaltered, on March 11, 2025 at 15:35 UTC. If you believe the information included in the content is inaccurate or outdated and requires editing or removal, please contact us at [email protected]